| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,625 |
4,325 |
$322K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,902 |
5,493 |
$286K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,586 |
2,583 |
$163K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
904 |
854 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,104 |
1,977 |
$25K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
589 |
580 |
$20K |
| 86328 |
|
315 |
298 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
778 |
385 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
622 |
616 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
53 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
354 |
349 |
$794.89 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
79 |
78 |
$757.30 |
| 81002 |
|
161 |
159 |
$463.68 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
706 |
670 |
$415.81 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
126 |
119 |
$295.85 |
| 99000 |
|
131 |
126 |
$0.00 |